$1.39 Billion is the total value of BRIDGER MANAGEMENT, LLC's 35 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 30.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $88,207,000 | +37.0% | 589,303 | +25.7% | 6.36% | +19.7% |
| ALC | Buy | ALCON INC | $80,447,000 | +6.4% | 1,422,079 | +9.6% | 5.80% | -7.1% |
| CNC | Buy | CENTENE CORP DEL | $77,306,000 | +284.9% | 1,229,609 | +164.9% | 5.58% | +236.1% |
| GDDY | Sell | GODADDY INCcl a | $74,518,000 | -1.0% | 1,097,145 | -3.8% | 5.38% | -13.6% |
| HCA | Buy | HCA HEALTHCARE INC | $72,760,000 | +97.9% | 492,256 | +61.2% | 5.25% | +72.8% |
| ERI | Sell | ELDORADO RESORTS INC | $70,160,000 | +36.1% | 1,176,393 | -9.0% | 5.06% | +18.8% |
| POST | Sell | POST HLDGS INC | $62,846,000 | -0.9% | 576,043 | -3.8% | 4.53% | -13.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $53,890,000 | +90.5% | 467,918 | +33.0% | 3.89% | +66.3% |
| GDS | Sell | GDS HLDGS LTDsponsored ads | $51,053,000 | +8.5% | 989,787 | -15.7% | 3.68% | -5.3% |
| MS | Sell | MORGAN STANLEY | $49,763,000 | -7.8% | 973,461 | -23.0% | 3.59% | -19.5% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $48,304,000 | +28.6% | 2,932,865 | +10.2% | 3.48% | +12.2% |
| CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $48,246,000 | -20.7% | 99,459 | -32.6% | 3.48% | -30.8% |
| ZGNX | Buy | ZOGENIX INC | $46,263,000 | +54.9% | 887,459 | +19.0% | 3.34% | +35.3% |
| HUM | Sell | HUMANA INC | $45,590,000 | -29.3% | 124,387 | -50.7% | 3.29% | -38.3% |
| LKQ | Sell | LKQ CORP | $45,578,000 | +8.3% | 1,276,708 | -4.6% | 3.29% | -5.4% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $43,655,000 | +14.4% | 1,981,633 | -25.5% | 3.15% | -0.2% |
| NTRA | New | NATERA INC | $42,205,000 | – | 1,252,746 | +100.0% | 3.04% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $40,463,000 | -9.9% | 1,721,816 | -29.0% | 2.92% | -21.3% |
| LIVN | New | LIVANOVA PLC | $38,290,000 | – | 507,621 | +100.0% | 2.76% | – |
| MGM | Sell | MGM RESORTS INTERNATIONAL | $38,041,000 | -4.9% | 1,143,396 | -20.8% | 2.74% | -17.0% |
| VRSN | VERISIGN INC | $33,257,000 | +2.1% | 172,604 | 0.0% | 2.40% | -10.8% | |
| ETSY | ETSY INC | $28,440,000 | -21.6% | 641,994 | 0.0% | 2.05% | -31.5% | |
| SHAK | Buy | SHAKE SHACK INCcl a | $27,213,000 | -23.5% | 456,828 | +25.9% | 1.96% | -33.2% |
| MDCO | Sell | MEDICINES CO | $25,907,000 | -63.2% | 305,002 | -78.3% | 1.87% | -67.9% |
| QDEL | New | QUIDEL CORP | $21,511,000 | – | 286,697 | +100.0% | 1.55% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $21,173,000 | +61.5% | 1,907,492 | -18.3% | 1.53% | +41.0% |
| New | MEDICINES COnote 3.500% 1/1 | $20,036,000 | – | 5,867,000 | +100.0% | 1.44% | – | |
| WORK | SLACK TECHNOLOGIES INC | $18,247,000 | -5.3% | 811,713 | 0.0% | 1.32% | -17.3% | |
| PVG | Sell | PRETIUM RES INC | $15,653,000 | -17.6% | 1,406,412 | -14.8% | 1.13% | -28.1% |
| TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $14,700,000 | +42.4% | 1,500,000 | 0.0% | 1.06% | +24.3% | |
| MSGS | New | MADISON SQUARE GARDEN CO NEWcl a | $13,175,000 | – | 44,784 | +100.0% | 0.95% | – |
| LBRDA | Sell | LIBERTY BROADBAND CORP | $10,940,000 | -65.7% | 87,833 | -71.3% | 0.79% | -70.1% |
| ATRC | New | ATRICURE INC | $8,502,000 | – | 261,524 | +100.0% | 0.61% | – |
| DXCM | Sell | DEXCOM INC | $7,831,000 | -45.2% | 35,800 | -62.6% | 0.56% | -52.1% |
| BRBR | New | BELLRING BRANDS INC | $2,129,000 | – | 100,000 | +100.0% | 0.15% | – |
| GDEN | Exit | GOLDEN ENTMT INC | $0 | – | -516,742 | -100.0% | -0.57% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -2,251,809 | -100.0% | -3.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERISIGN INC | 40 | Q1 2023 | 5.2% |
| TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
| MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
| ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
| POST HLDGS INC | 33 | Q4 2022 | 6.1% |
| TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
| ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
| GODADDY INC | 28 | Q3 2023 | 8.9% |
| CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
| Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
| Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
| TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
| CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
| SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
| Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
| ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
| PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR/A | 2024-03-25 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.